!"#!$#!!% !% !"#$%&'($)#"*"$+(),( /0(1")#"2/3(-45/3(-516/(( 4)2/"7'&89)2/(,&):(:'*;82"/:/(),(8*9)2/(( 827(,)&(&"/<(8//'//:'2$( &%% '()*+,+-%./0%12)3%4))-))5-(+%672-(7-)&%8+0-79+%8(2:-0)2+;&%<9-%=-+9-0>?(@)% %?(@%% A/0>@%B-?>+9%C0D?(2E?*/(%F/>>?G/0?*(D%F-(+0-%% ./0%H(:20/(5-(+?>%B-?>+9%12)3%4))-))5-(+% % O S S T I I Æ L L V S T R A N O S L V I I T I?0*(%:?(%@-(%J-0D% Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl 6+0,7+,0-%?7*:2+;%0->?*/()92K)%L2+92(%+9-%D0/,K%/.%% M/>;B?>/D-(?+-@%40/5?*7%B;@0/7?0G/()%NMB4B)O% MFJ)% P-))%@2/Q2(%>23-% O O Cl Cl Cl Cl R2/Q2(% R2G-(E/.,0?()% I/0-%/0+9/% ),G)*+,*/(% !"##$ "%&'()*+,$ /)0.+$ B-?+%)9/73% K0/+-2()% #1'213$ $40+('3+150$6030$ R1H% 491% 491% 40(+%M0/+% 51=4)% "789:9;$ 9:<;9=9% >0&*?')1+,$ "*4/13'@031/1&%$ $$$$$$$$$$!'21/1&%% 8=#A$ !"#!$#!!% $% <9?(3%;/,%)/%5,79%./0%72*(D%,)%?>+9/,D9% /S-(%L2+9%+9-%L0/(D%)72-(*T7%0?*/(?>-U% $V!V%H:?>,?*/(% W!XVV%72+?*/()% $V!V%H:?>,?*/(% Y%XVV%72+?*/()% !"#!$#!!% Z% 8)-%/.%<H[)%?(@%<H\)%./0%?G2/*7%5?+027-)% • F/(7-0(%?G/,+%?KK>27?*/(%<H[]<H\%?KK0/?79%+/%?G2/*7%-(:20/(5-(+?>% 5?+027-)%),79%?)%)/2>&%)-@25-(+&%-+7^%% % • M0-)-(+%<H[%)79-5-%?(@%?))/72?+-@%<H\)%./0%-QK/),0-%:2?%@2-+?0;%2(+?3-% )2+,?*/()%N<H[)%G?)-@%>?0D->;%/(%,K+?3-%)+,@2-)O% • Applica'on*these*‘intake*or*inges'on’*TEFs*has*limited*toxicological* relevance*and*use*for*risk*assessment*of*environmental*matrices* %% • 4)K-7+)%0-@,7-@%G2/?:?2>?G2>2+;&%-(:20/(5-(+?>%.?+-%?(@%+0?()K/0+%(/+%2(% K0-)-(+%1HM]<H[%)+,@2-)%-:?>,?+-@% C(-%/0@-0%/.%5?D(2+,@-%@-7>2(-%2(%G?73D0/,(@%9,5?(% -QK/),0-%)2(7-%!_`Va)%@,-%+/%0-5-@2?>%?7*/()% I2Q+,0-)%/.%MFRR)&%MFR[)%?(@%RP#MFJ)% %)*>>%?%9-?>+9%02)3b% !"#!$#!!% "% !=(>82(7'2(5'&?(@(A=(B=(482$)2(CDEFEG( (H(IJ)K8J(B))7K)&2'(5%&7'2(),(1"/'8/'L(MN.OB6AI=(P2(Q&'Q=( Hc-7+%0?(D-%)+?0+)% $X#XV%KD%<H\)%]D% >2K2@%2(%9,5?(% G>//@%?(@%52>3% J0-?)d-@%2(.?(+)%7?(%-Q7 @%ABC%<R'%,K%+/%+L/%/0@-0)%/.% 5?D(2+,@-%./0%Z#e%5/(+9)% !=(>82(7'2(5'&?(@(A=(B=(482$)2(CDEFEG( (H(IJ)K8J(B))7K)&2'(5%&7'2(),(1"/'8/'L(MN.OB6AI=(P2(Q&'Q=( !"#!$#!!% X% HQK/),0-%792>@0-(%/S-(%)2D(2T7?(+%?G/:-%<R'%?+%,KK-0%0?(D-% -QK/),0-%N_X%/0%__%K-07-(*>-O% !=(>82(7'2(5'&?(@(A=(B=(482$)2(CDEFEG( (H(IJ)K8J(B))7K)&2'(5%&7'2(),(1"/'8/'L(MN.OB6AI=(P2(Q&'Q=( H)*5?*/(%/.%(,5G-0%/.%A#H,0/K-%792>@0-(%-Q7 @2(D% +9-%<R'%)2D(2T7?(+>;%Nf%!VQO%2(%K-02/@%$VVX#$V!V% !=(>82(7'2(5'&?(@(A=(B=(482$)2(CDEFEG( (H(IJ)K8J(B))7K)&2'(5%&7'2(),(1"/'8/'L(MN.OB6AI=(P2(Q&'Q=( !"#!$#!!% e% R2c-0-(+%)? +;%)+?(@?0@)%./0%@2/Q2(%>23-%7/5K/,(@)% N<H\)O%?(@%RR<%L2+9%7?>7,>?+-@%-g,2:?>-(+%9,5?(%52>3% >-:->)^% % !"#!$#!!% `% !"#!$#!!% h% 69/,>@%L-%L/00;b% % % 6-i(D%?%!#B%2)%K0/:2@-@%./0%>2 %*5-%K0/+-7*/(%?(@% .+.*))%%@-02:-@%.0/5%/C4'31/$02(041,03&+$N0/@-(+)O%% % #1'213$!#B;$!DB$*3E$!>B$9?:-%*),'+&$02/).+150)%$E04150E$ F4',$+C'4&$G,0$(0413*&*)$+&.E10+$L2+92(%?%j)-()2*:-% L2(@/La%/.%>2 % % %A-2D9+%/.%-:2@-(7-%K/2(+)%+/L?0@)%C.,*3+%G (%)0++$ +03+1G50%N$#!V%*5-)bO%+9?(%0/@-(+)% % [/0%##!%5/)+%7/,(+02-)%?0-%?+%?%H+*F0$)050)I$F'4$?40*+J0E$ 13F*3&+$ $ $ . Applica'on*these*‘intake*or*inges'on’*TEFs*has*limited*toxicological* relevance *and* use *for* risk* assessment *of* environmental*matrices* %% • 4)K-7+)%0-@,7-@%G2/?:?2>?G2>2+;&%-(:20/(5-(+?>%.?+-%?(@%+0?()K/0+%(/+%2(% K0-)-(+%1HM]<H[%)+,@2-)%-:?>,?+-@% C(-%/0@-0%/.%5?D(2+,@-%@-7>2(-%2(%G?73D0/,(@%9,5?(% -QK/),0-%)2(7-%!_`Va)%@,-%+/%0-5-@2?>%?7*/()% I2Q+,0-)%/.%MFRR)&%MFR[)%?(@%RP#MFJ)% %)*>>%?%9-?>+9%02)3b% !"#!$#!!% "% !=(>82(7'2(5'&?(@(A=(B=(482$)2(CDEFEG( (H(IJ)K8J(B))7K)&2'(5%&7'2(),(1"/'8/'L(MN.OB6AI=(P2(Q&'Q=( Hc-7+%0?(D-%)+?0+)% $X#XV%KD%<H)%]D% >2K2@%2(%9,5?(% G>//@%?(@%52>3% J0-?)d-@%2(.?(+)%7?(%-Q7